Non-adherence to antiplatelet therapy - which prevents blood clots following percutaneous coronary intervention (PCI) - was associated with higher rates of both ischemic and bleeding events at 30 days. Results of the PARIS registry were presented at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation...
More...
More...